Regulatory roles for NKT cell ligands in environmentally induced autoimmunity

Journal of Immunology

Volumn 181, Issue 10, 2008, Pages 6779-6788

  Vas, Jaya ^a   Mattner, Jochen ^b   Richardson, Stewart ^c   Ndonye, Rachel ^c   Gaughan, John P ^a   Howell, Amy ^c   Monestier, Marc ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^c UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENVIRONMENTAL CHEMICAL; MERCURY; METAL; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 9; AUTOANTIBODY; AUTOANTIGEN; GLYCOSPHINGOLIPID; IMMUNOLOGICAL ADJUVANT; LIGAND; MERCURIC CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CONTROLLED STUDY; DISEASE EXACERBATION; ENVIRONMENTAL FACTOR; EXPERIMENTAL MODEL; GENETIC SUSCEPTIBILITY; IMMUNE SYSTEM; IMMUNOLOGICAL TOLERANCE; INNATE IMMUNITY; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SPHINGOMONAS; SPHINGOMONAS CAPSULATA; STEADY STATE; ANIMAL; BLOOD; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; ENVIRONMENTAL EXPOSURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GRAM NEGATIVE INFECTION; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; AUTOANTIBODIES; AUTOANTIGENS; AUTOIMMUNE DISEASES; AUTOIMMUNITY; ENVIRONMENTAL EXPOSURE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GLYCOSPHINGOLIPIDS; GRAM-NEGATIVE BACTERIAL INFECTIONS; IMMUNE TOLERANCE; LIGANDS; LYMPHOCYTE ACTIVATION; MERCURIC CHLORIDE; MICE; MICE, INBRED C57BL; SPHINGOMONAS; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES; TOLL-LIKE RECEPTORS;

EID: 58149184314     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.10.6779     Document Type: Article

References (55)

1. Lawrence, D. A., and M. J. McCabe, Jr. 2002. Immunomodulation by metals. Int. Immunopharmacol. 2: 293-302.
2. Cardenas, A., H. Roels, A. M. Bernard, R. Barbon, J. P. Buchet, J. Rosello, G. Hotter, A. Mutti, and I. Franchini. 1998. Markers of early renal changes induced by industrial pollutants. I. Application to workers exposed to mercury vapors. Br. J. Ind. Med. 50: 17-27. (Pubitemid 23030200)
3. Enestrom, S., and P. Hultman. 1995. Does amalgam affect the immune system? A controversial issue. Int. Arch. Allergy Immunol. 106: 180-203.
4. Goyer, R. A. 1990. Environmentally related diseases of the urinary tract. Med. Clin. N. Am. 74: 377-389.
5. Moszczynski, P., S. Slowinski, J. Rutkowski, S. Bem, and D. Jakus-Stoga. 1995. Lymphocytes, T and NK cells, in men occupationally exposed to mercury vapours. Int. J. Occup. Med. Environ. Health 8: 49-56.
6. Pollard, K. M., and P. Hultman. 1997. Effects of mercury on the immune system. Met. Ions Biol. Syst. 34: 421-440.
7. Pelletier, L., M. Castedo, B. Bellon, and P. Druet. 1994. Mercury and autoimmunity. In Immunotoxicology and Immunopharmacology. J. H. Dean, M. I. Luster, A. E. Munson, and I. Kimber, eds. Raven Press, New York, pp. 539-552.
8. Rowley, B., and M. Monestier. 2005. Mechanisms of heavy metal-induced autoimmunity. Mol. Immunol. 42: 833-838.
9. Kono, D. H., M. S. Park, A. Szydlik, K. M. Haraldsson, J. D. Kuan, D. L. Pearson, P. Hultman, and K. M. Pollard. 2001. Resistance to xenobiotic-induced autoimmunity maps to chromosome 1. J. Immunol. 167: 2396-2403.
10. Nielson, J. B., and P. Hultman. 2002. Mercury-induced autoimmunity in mice. Environ. Health Perspect. 110: 877-881.
11. 2-treated mice. Clin. Immunol. Immunopathol. 84: 328-337.
12. Kawano, T., J. Cui, Y. Koezuka, I. Toura, Y. Kaneko, K. Motoki, H. Ueno, R. Nakagawa, H. Sato, E. Kondo, et al. 1997. CD1d-restricted and TCR-mediated activation of Vα14 NKT cells by glycosylceramides. Science 278: 1626-1629. (Pubitemid 27516282)
13. Brossay, L., M. Chioda, N. Burdin, Y. Koezuka, G. Casorati, P. Dellabona, and M. Kronenberg. 1998. CD1d-mediated recognition of an α- galactosylceramide by natural killer T cells is highly conserved through mammalian evolution. J. Exp. Med. 188: 1521-1528. (Pubitemid 28489589)
14. Brossay, L., O. Naidenko, N. Burdin, J. Matsuda, T. Sakai, and M. Kronenberg. 1998. Structural requirements for galactosylceramide recognition by CD1-restricted NKT cells. J. Immunol. 161: 5124-5128. (Pubitemid 28519066)
15. + NK T lymphocytes. J. Immunol. 161: 3271-3281.
16. Liu, Y., R. D. Goff, D. Zhou, J. Mattner, B. A. Sullivan, A. Khurana, I. C. Cantu, E. V. Ravkov, C. C. Ibegbu, J. D. Altman, et al. 2006. A modified α-galactosyl ceramide for staining and stimulating natural killer T cells. J. Immunol. Methods 312: 34-39. (Pubitemid 43795980)
17. Sidobre, S., K. J. L. Hammond, L. Benazet-Sidobre, S. D. Maltsev, S. K. Richardson, R. M. Ndonye, A. R. Howell, T. Sakai, G. S. Besra, S. A. Porcelli, and M. Kronenberg. 2004. The T cell antigen receptor expressed by Vα14i NKT cells has a unique mode of glycosphingolipid antigen recognition. Proc. Natl. Acad. Sci. USA 101: 12254-12259. (Pubitemid 39145430)
18. Mattner, J., K. L. DeBord, N. Ismail, R. D. Goff, C. Cantu, D. Zhou, P. Saint-Mezard, V. Wang, Y. Gao, N. Yin, et al. 2005. Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature 434: 525-529. (Pubitemid 40477062)
19. Christen, U., and M. G. von Herrath. 2005. Infections and autoimmunity: good or bad? J. Immunol. 174: 7481-7486.
20. Via, C. S., P. Nguyen, F. Niculescu, J. Papadimitriou, D. Hoover, and E. K. Silbergeld. 2003. Low-dose exposure to inorganic mercury accelerates disease and mortality in acquired murine lupus. Environ. Health Perspect. 111: 1273-1277.
21. Bagenstose, L. M., P. Salgame, and M. Monestier. 1998. IL-12 down-regulates autoantibody production in mercury-induced autoimmunity. J. Immunol. 160: 1612-1617.
22. Armitage, P., and G. Berry. 1994. Statistical Methods in Medical Research, 3rd Ed. Blackwell Science, Cambridge, pp. 395-398.
23. Conover, W. J., and R. L. Iman. 1981. Rank transformations as a bridge between parametric and nonparametric statistics. Am. Stat. 35: 124-129.
24. Harter, H. L. 1961. Expected values of normal order statistics. Biometrika 48: 151-165.
25. + Tregs and NKT cells: regulators regulating regulators. Trends Immunol. 27: 322-327.
26. + T regulatory cells in the prevention of autoimmune myasthenia. J. Immunol. 175: 7898-7904.
27. Kumar, H., A. Belperron, S. W. Barthold, and L. K. Bockenstedt. 2000. CD1d deficiency impairs murine host defense against the spirochete, Borrelia burgdorferi. J. Immunol. 165: 4797-4801. (Pubitemid 30809401)
28. Nieuwenhuis, E. E. S., T. Matsumoto, M. Exley, R. A. Schleipman, J. Glickman, D. T. Bailey, N. Corazza, S. P. Colgan, A. B. Onderdonk, and R. S. Blumberg. 2002. CD1d-dependent macrophage-mediated clearance of Pseudomonas aeruginosa from lung. Nat. Med. 8: 588-593. (Pubitemid 34633436)
29. Kinjo, Y., D. Wu, G. Kim, G. W. Xing, M. A. Poles, D. D. Ho, M. Tsuji, K. Kawahara, C. H. Wong, and M. Kronenberg. 2005. Recognition of bacterial glycosphingolipids by natural killer T cells. Nature 434: 520-525. (Pubitemid 40477061)
30. Kinjo, Y., and M. Kronenberg. 2005. Vα14i NKT cells are innate lymphocytes that participate in the immune response to diverse microbes. J. Clin. Immunol. 25: 522-533. (Pubitemid 43011744)
31. Jahng, A. W., I. Maricic, B. Pedersen, N. Burdin, O. Naidenko, M. Kronenberg, Y. Koezuka, and V. Kumar. 2001. Activation of natural killer T cells potentiates or prevents experimental autoimmune encephalomyelitis. J. Exp. Med. 194: 1789-1799. (Pubitemid 34028658)
32. Yang, J. Q., V. Saxena, H. Xu, L. Van Kaer, C. R. Wang, and R. R. Singh. 2003. Repeated α-galactosylceramide administration results in expansion of NKT cells and alleviates inflammatory dermatitis in MRL-lpr/lpr mice. J. Immunol. 171: 4439-4446.
33. Coppieters, K., K. Van Beneden, P. Jacques, P. Dewint, A. Vervloet, B. Vander Cruyssen, S. Van Calenbergh, G. Chen, R. W. Franck, G. Verbruggen, et al. 2007. A single early activation of invariant NKT cells confers long-term protection against collagen-induced arthritis in a ligand-specific manner. J. Immunol. 179: 2300-2309.
34. Pal, E., T. Tabira, T. Kawano, M. Taniguchi, S. Miyake, and T. Yamamura. 2001. Costimulation-dependent modulation of experimental autoimmune encephalomyelitis by ligand stimulation of Vα14 NKT cells. J. Immunol. 166: 662-668. (Pubitemid 32038491)
35. Miyamoto, K., S. Miyake, and T. Yamamura. 2001. A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells. Nature 413: 531-534. (Pubitemid 32938752)
36. Hermans, I. F., J. D. Silk, U. Gileadi, S. H. Masri, D. Shepherd, K. J. Farrand, M. Salio, and V. Cerundolo. 2007. Dendritic cell function can be modulated through cooperative actions of TLR ligands and invariant NKT cells. J. Immunol. 178: 2721-2729.
37. Tang, Q., J. Y. Adams, C. Penaranda, K. Melli, E. Piaggio, E. Sgouroudis, C. A. Piccirillo, B. L. Salomon, and J. A. Bluestone. 2008. Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction. Immunity 28: 687-697.
38. Steinman, R. M., D. Hawiger, and M. C. Nussenzweig. 2003. Tolerogenic dendritic cells. Annu. Rev. Immunol. 21: 685-711.
39. Steinman, R. M., and M. C. Nussenzweig. 2002. Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance. Proc. Natl. Acad. Sci. USA 99: 351-358. (Pubitemid 34060366)
40. Inaba, K., S. Turley, T. Iyoda, F. Yamaide, S. Shimoyama, C. R. Sousa, R. N. Germain, I. Mellman, and R. M. Steinman. 2000. The formation of immunogenic major histocompatibility complex class II-peptide ligands in lysosomal compartments of dendritic cells is regulated by inflammatory stimuli. J. Exp. Med. 191: 927-936. (Pubitemid 30691395)
41. + cytotoxic T lymphocyte priming capacity upon activation by T helper cell-independent or -dependent stimuli. J. Exp. Med. 192: 145-150.
42. Rutella, S., S. Danese, and G. Leone. 2006. Tolerogenic dendritic cells: cytokine modulation comes of age. Blood 108: 143d5-1440. (Pubitemid 44316106)
43. Menges, M., S. Ner, C. Voigtlander, H. Schindler, N. A. Kukutsch, C. Bogdan, K. Erb, G. Schuler, and M. B. Lutz. 2001. Repetitive injections of dendritic cells matured with tumor necrosis factor α induce antigen-specific protection of mice from autoimmunity. J. Exp. Med. 195: 15-22. (Pubitemid 34074492)
44. Lutz, M. B., and G. Schuler. 2002. Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity? Trends Immunol. 23: 445-449.
45. Reis e Sousa, C. 2006. Dendritic cells in a mature age. Nat. Rev. Immunol. 6: 476-483.
46. Fujii, S. I., K. Shimizu, C. Smith, L. Bonifaz, and R. M. Steinman. 2003. Activation of natural killer T cells by α-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein. J. Exp. Med. 198: 267-279.
47. + invariant NKT cells for the infectious spread of tolerance and the induction of specific regulatory T cells. J. Immunol. 173: 1043-1050.
48. Sonoda, K. H., T. Nakamura, H. A. Young, D. Hart, P. Carmeliet, and J. Stein-Streilein. 2007. NKT cell-derived urokinase-type plasminogen activator promotes peripheral tolerance associated with eye. J. Immunol. 179: 2215-2222.
49. Ehirchiou, D., Y. Xiong, G. Xu, W. Chen, Y. Shi, and L. Zhang. 2007. CD11b facilitates the development of peripheral tolerance by suppressing Th17 differentiation. J. Exp. Med. 204: 1519-1524. (Pubitemid 47048019)
50. Pollard, K. M., D. L. Pearson, P. Hultman, T. N. Deane, U. Lindh, and D. H. Kono. 2001. Xenobiotic acceleration of idiopathic systemic autoimmunity in lupus-prone bxsb mice. Environ. Health Perspect. 109: 27-33.
51. Bendelac, A., P. B. Savage, and L. Teyton. 2007. The biology of NKT cells. Annu. Rev. Immunol. 25: 297-336.
52. Bagenstose, L. M., P. Salgame, and M. Monestier. 1999. Murine mercury-induced autoimmunity: a model of chemically related autoimmunity in humans. Immunol. Res. 20: 67-78.
53. Zajonc, D. M., C. Cantu, J. Mattner, D. Zhou, P. B. Savage, A. Bendelac, I. A. Wilson, and L. Teyton. 2005. Structure and function of a potent agonist for the semi-invariant natural killer T cell receptor. Nat. Immunol. 6: 810-818. (Pubitemid 43090467)
54. Goff, R. D., Y. Gao, J. Mattner, D. Zhou, N. Yin, C. Cantu, L. Teyton, A. Bendelac, and P. B. Savage. 2004. Effects of lipid chain lengths in α-galactosylceramides on cytokine release by natural killer T cells. J. Am. Chem. Soc. 126: 13602-13603.
55. Yu, K. O. A., J. S. Im, A. Molano, Y. Dutronc, P. A. Illarionov, C. Forestier, N. Fujiwara, I. Arias, S. Miyake, T. Yamamura, et al. 2005. Modulation of CD1d-restricted NKT cell responses by using N-acyl variants of α-galactosylceramides. Proc. Natl. Acad. Sci. USA 102: 3383-3388.